Safety and Feasibility Study of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess Cavities
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The objectives of this Phase 1 study are to evaluate the safety and feasibility of
methylene-blue-mediated photodynamic therapy (MB-PDT) performed at the time of abscess
drainage to treat deep tissue abscesses. Safety will be evaluated by physical examination and
imaging and laboratory studies in order to identify adverse events that may be induced by
MB-PDT. We hypothesize that MB-PDT will be a safe and feasible intervention for this patient
population.
Phase:
Phase 1
Details
Lead Sponsor:
University of Rochester
Treatments:
Methylene Blue Pharmaceutical Solutions Soybean oil, phospholipid emulsion